What are examples of intranasal corticosteroid sprays, including their generic names and typical adult dosing regimens?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Intranasal Corticosteroid Sprays: Examples and Dosing

Multiple intranasal corticosteroid formulations are available for treating allergic rhinitis and rhinosinusitis, with specific FDA-approved dosing regimens that vary by age and indication. 1

Available Intranasal Corticosteroid Preparations

Over-the-Counter Options

  • Triamcinolone acetonide (Nasacort Allergy 24HR): 55 µg per spray, aqueous formulation 1
    • Ages 2-5 years: 1 spray per nostril daily
    • Ages 6-11 years: 2 sprays per nostril daily
    • Ages ≥12 years: 2 sprays per nostril once or twice daily
    • Common side effects: pharyngitis, epistaxis, cough 1

Prescription Formulations

  • Mometasone furoate (Nasonex): 50 µg per spray, aqueous 1

    • Ages 2-11 years: 1 spray per nostril daily
    • Ages ≥12 years: 2 sprays per nostril daily
    • For nasal polyps (≥18 years): 2 sprays per nostril twice daily
    • Common side effects: headache, viral infection, pharyngitis, epistaxis, cough 1
  • Fluticasone propionate (Flonase): 50 µg per spray, aqueous 1

    • Ages 4 years to adult: 1 spray per nostril daily
    • Adults: 2 sprays per nostril daily
    • Available in generic form 1
    • Common side effects: headache, pharyngitis, epistaxis, nasal burning or irritation 1
  • Fluticasone furoate (Veramyst): 27.5 µg per spray, suspension 1

    • Ages 2-11 years: 1-2 sprays per nostril daily
    • Ages >11 years: 2 sprays per nostril daily
    • Common side effects: epistaxis, headache, pharyngolaryngeal pain 1
  • Budesonide (Rhinocort AQ): 32 µg per spray, aqueous 1

    • Ages ≥6 years: 2 sprays per nostril twice daily OR 4 sprays per nostril in the morning
    • Common side effects: epistaxis, pharyngitis, bronchospasm, coughing, nasal irritation 1
    • Pregnancy category B rating 2
  • Ciclesonide (Omnaris): 50 µg per spray, aqueous suspension 1

    • Ages ≥6 years: 2 sprays per nostril daily
    • Common side effects: epistaxis, headache, nasopharyngitis 1
  • Ciclesonide (Zetonna): 37 µg per spray, HFA-propelled aerosol 1

    • Ages ≥12 years: 1 spray per nostril daily
    • Common side effects: nasal discomfort, epistaxis, headache 1
  • Flunisolide (Nasalide or Nasarel): 25 µg per spray, 0.025% solution 1

    • Ages 6-14 years: 1 spray per nostril 3 times daily OR 2 sprays per nostril twice daily
    • Ages >14 years: 2 sprays per nostril 2 or 3 times daily
    • Available in generic form 1
    • Common side effects: epistaxis, pharyngitis, cough, aftertaste, nasal burning 1

Clinical Efficacy Considerations

Intranasal corticosteroids are the most effective monotherapy for seasonal and perennial allergic rhinitis, superior to oral antihistamines and leukotriene receptor antagonists. 1 They effectively control all four major symptoms: sneezing, itching, rhinorrhea, and nasal congestion 1

Onset of Action

  • Therapeutic effect occurs within 12 hours in most patients 1
  • Some patients experience relief as early as 3-4 hours 1
  • For optimal delivery, consider short-term nasal decongestant use (several days) when initiating therapy if nasal airway is significantly obstructed 1

Comparative Effectiveness

  • No clear evidence that one intranasal corticosteroid is more effective than another for treating allergic rhinitis 3, 4
  • All formulations demonstrate similar efficacy and adverse event profiles when used at recommended doses 2, 5
  • Higher doses may provide marginally better polyp reduction but increase epistaxis risk (RR 2.06,95% CI 1.20-3.54) without clear symptom benefit 3

Safety Profile

Common Adverse Effects

  • Epistaxis is the most common side effect, occurring in 5-10% of patients regardless of formulation 5
    • Placebo sprays also cause epistaxis in 10-15% of patients 4
    • Most cases involve minor bleeding (streaks of blood in mucus) rather than frank hemorrhage 3
    • Direct spray away from nasal septum to minimize risk 1

Systemic Effects

  • Minimal systemic corticosteroid effects at recommended doses in adults 1
  • No clinically significant HPA axis suppression demonstrated in children 1
  • Transient growth effects may occur in children with specific products, though this is dose-dependent 1
  • Use lowest effective dose in pediatric patients 1

Important Contraindications

  • History of hypersensitivity to medication or components (applies to all formulations) 1

Key Clinical Pearls

  • Continuous daily use is more effective than as-needed administration for seasonal allergic rhinitis, though PRN use (55-62% of days) can provide significant relief 1
  • Patient preference regarding sensory attributes (taste, smell, nasal sensation) may affect adherence—budesonide and triamcinolone are generally preferred over mometasone and fluticasone based on sensory characteristics 2
  • Intranasal corticosteroids should be considered for initial treatment without requiring prior trial of antihistamines or oral decongestants 1
  • Periodically examine nasal septum to ensure no mucosal erosions are developing 1

Related Questions

What are examples of intranasal corticosteroid sprays (generic and brand names)?
What is the most appropriate initial evaluation and management for a 26‑year‑old woman with a 2‑3‑week history of severe right‑breast pain radiating to the shoulder and neck, no palpable mass, skin changes, nipple discharge, or systemic symptoms, and a recent cessation of breastfeeding?
In a 15‑year‑old male with persistent left lower‑quadrant abdominal tenderness and bruising, right‑sided back pain radiating to the ribs, and new left great‑toe stabbing pain with tingling after a recent appendectomy, what imaging studies and medical management are indicated?
How should a 23-year-old male presenting with dysuria and urethral discharge be evaluated and treated?
In a 23‑year‑old woman with dysuria, burning and tearing sensation during and after intercourse, should she be referred to a gynecologist first or a urologist?
What are the clinical features, severity spectrum, and management options for beta thalassemia?
Is it safe for a female patient on escitalopram 10 mg daily and venlafaxine 75 mg daily to use a combined oral contraceptive containing 1.5 mg estradiol and 2.5 mg nomegestrol acetate?
What is the appropriate intravenous furosemide (Lasix) dose for a patient with hypercalcemia (serum calcium 12.7 mg/dL)?
Is beta‑thalassemia associated with pernicious anemia or polycythemia?
What pre‑procedure measures should be taken for patients prone to post‑inflammatory hyperpigmentation?
What is the appropriate evaluation and management of an anterior neck injury, including airway protection, imaging, antibiotics, and surgical intervention?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.